← Back to Search

Behavioural Intervention

iEngage Social Network Intervention for HIV/AIDS

N/A

Waitlist Available

Led By Tiarney Ritchwood, Ph.D.

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 month, and 12 month follow up

Awards & highlights

Study Summary

This trial will test a social network intervention to improve HIV-related outcomes for ALWH in South Africa.

Who is the study for?

This trial is for adolescents living with HIV in South Africa who are willing to let researchers access their clinic data, live in the study area, and can consent or bring a social network member to join the intervention.Check my eligibility

What is being tested?

The 'iEngage' intervention is being tested to see if it improves retention in HIV care and antiretroviral therapy adherence among adolescents by leveraging social support within their networks.See study design

What are the potential side effects?

Since 'iEngage' focuses on social support rather than medication, there may not be direct medical side effects. However, participants might experience emotional or psychological impacts from engaging with their social networks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 month, and 12 month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 month, and 12 month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 month, and 12 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability: exit interviews

Feasibility: exit interviews

Secondary outcome measures

Change in ART adherence

Change in HIV knowledge

Change in HIV stigma & discrimination

+18 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: iEngageExperimental Treatment1 Intervention

The intervention is a network-based, social support intervention to improve ALWH retention in HIV care and ART adherence. The specific intervention will be developed during Aim 2 of the study and uses qualitative findings, along with data from Aim 1, to develop an interventions that integrates participant feedback and borrows components from two existing interventions

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,244 Previous Clinical Trials

1,004,758 Total Patients Enrolled

Duke UniversityLead Sponsor

2,367 Previous Clinical Trials

3,424,817 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,789 Previous Clinical Trials

2,690,400 Total Patients Enrolled

Media Library

iEngage (tentative title) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04077047 — N/A

HIV/AIDS Clinical Trial 2023: iEngage (tentative title) Highlights & Side Effects. Trial Name: NCT04077047 — N/A

iEngage (tentative title) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04077047 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must be met for potential participants of this research?

"This medical research is in search of 30 individuals aged between 15 and 21 who are afflicted with AIDS. In addition to this, they must be local residents, capable of giving consent or assent, amenable to granting the investigators access to their clinic data for retention assessment and ART compliance purposes. It is also mandatory that each selected participant brings an associate from their personal network into the study as well."

Answered by AI

What is the ultimate aim of this scientific research?

"This 12 month study seeks to gauge the feasibility of its exit interviews. Alongside this, it will measure changes in social support via a questionnaire or interview, alterations in viral load drawn from existing records and shifts in trust which will also be gauged through questioning."

Answered by AI

Are there any enrolment opportunities for this clinical trial?

"Per information accessed on clinicaltrials.gov, this experiment has ceased recruiting patients; the original posting date was January 1st 2023 and it last received an update on September 22nd 2022. However, there are currently 514 other trials that still require participants to join."

Answered by AI